IRIS Accounts Production v24.3.2.46 04251937 Board of Directors 1.1.24 31.12.24 31.12.24 false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh042519372023-12-31042519372024-12-31042519372024-01-012024-12-31042519372022-12-31042519372023-01-012023-12-31042519372023-12-3104251937ns15:EnglandWales2024-01-012024-12-3104251937ns14:PoundSterling2024-01-012024-12-3104251937ns10:Director12024-01-012024-12-3104251937ns10:PrivateLimitedCompanyLtd2024-01-012024-12-3104251937ns10:SmallEntities2024-01-012024-12-3104251937ns10:AuditExempt-NoAccountantsReport2024-01-012024-12-3104251937ns10:SmallCompaniesRegimeForDirectorsReport2024-01-012024-12-3104251937ns10:SmallCompaniesRegimeForAccounts2024-01-012024-12-3104251937ns10:FullAccounts2024-01-012024-12-310425193712024-01-012024-12-3104251937ns10:Director22024-01-012024-12-3104251937ns10:Director32024-01-012024-12-3104251937ns10:Director42024-01-012024-12-3104251937ns10:Director52024-01-012024-12-3104251937ns10:CompanySecretary12024-01-012024-12-3104251937ns10:RegisteredOffice2024-01-012024-12-3104251937ns5:CurrentFinancialInstruments2024-12-3104251937ns5:CurrentFinancialInstruments2023-12-3104251937ns5:ShareCapital2024-12-3104251937ns5:ShareCapital2023-12-3104251937ns5:SharePremium2024-12-3104251937ns5:SharePremium2023-12-3104251937ns5:CapitalRedemptionReserve2024-12-3104251937ns5:CapitalRedemptionReserve2023-12-3104251937ns5:RetainedEarningsAccumulatedLosses2024-12-3104251937ns5:RetainedEarningsAccumulatedLosses2023-12-3104251937ns5:NetGoodwill2024-01-012024-12-3104251937ns5:IntangibleAssetsOtherThanGoodwill2024-01-012024-12-3104251937ns5:NetGoodwill2023-12-3104251937ns5:NetGoodwill2024-12-3104251937ns5:NetGoodwill2023-12-3104251937ns5:FurnitureFittings2023-12-3104251937ns5:ComputerEquipment2023-12-3104251937ns5:FurnitureFittings2024-01-012024-12-3104251937ns5:ComputerEquipment2024-01-012024-12-3104251937ns5:FurnitureFittings2024-12-3104251937ns5:ComputerEquipment2024-12-3104251937ns5:FurnitureFittings2023-12-3104251937ns5:ComputerEquipment2023-12-3104251937ns5:CostValuation2023-12-3104251937ns5:WithinOneYearns5:CurrentFinancialInstruments2024-12-3104251937ns5:WithinOneYearns5:CurrentFinancialInstruments2023-12-31
REGISTERED NUMBER: 04251937 (England and Wales)















UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2024

FOR

THE NURSERY RESEARCH & PLANNING LIMITED

THE NURSERY RESEARCH & PLANNING LIMITED (REGISTERED NUMBER: 04251937)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


THE NURSERY RESEARCH & PLANNING LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31 DECEMBER 2024







DIRECTORS: D M Alterman
N J Barnett
M Bigoni
P T McGowan
G D Simmonds





SECRETARY: N J Barnett





REGISTERED OFFICE: Victoria House
26 Queen Victoria Street
Reading
Berkshire
RG1 1TG





REGISTERED NUMBER: 04251937 (England and Wales)

THE NURSERY RESEARCH & PLANNING LIMITED (REGISTERED NUMBER: 04251937)

BALANCE SHEET
31 DECEMBER 2024

31.12.24 31.12.23
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 121,268 145,521
Tangible assets 5 14,088 14,670
Investments 6 2 2
135,358 160,193

CURRENT ASSETS
Debtors 7 1,701,489 2,084,333
Cash at bank and in hand 749,687 804,974
2,451,176 2,889,307
CREDITORS
Amounts falling due within one year 8 1,457,911 2,155,723
NET CURRENT ASSETS 993,265 733,584
TOTAL ASSETS LESS CURRENT
LIABILITIES

1,128,623

893,777

PROVISIONS FOR LIABILITIES 3,522 5,486
NET ASSETS 1,125,101 888,291

CAPITAL AND RESERVES
Called up share capital 4 4
Share premium 164,867 164,867
Capital redemption reserve 1 1
Retained earnings 960,229 723,419
1,125,101 888,291

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

THE NURSERY RESEARCH & PLANNING LIMITED (REGISTERED NUMBER: 04251937)

BALANCE SHEET - continued
31 DECEMBER 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 13 March 2025 and were signed on its behalf by:





D M Alterman - Director


THE NURSERY RESEARCH & PLANNING LIMITED (REGISTERED NUMBER: 04251937)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

1. STATUTORY INFORMATION

The Nursery Research & Planning Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

Revenue from contracts for the provision of professional services is recognised by reference to the stage of completion when the stage of completion, costs incurred and costs to complete can be estimated reliably. The stage of completion is calculated by comparing costs incurred, mainly in relation to contractual hourly staff rates and materials, as a proportion of total costs. Where the outcome cannot be estimated reliably, revenue is recognised only to the extent of the expenses recognised that it is probable will be recovered.

Goodwill
Goodwill represents the excess of the cost of acquisition of unincorporated businesses over the fair value of net assets acquired. It is initially recognised as an asset at cost and is subsequently measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is considered to have a finite useful life and is amortised on a systematic basis over its expected life, which is 10 years.

For the purposes of impairment testing goodwill is allocated to the cash-generating units expected to benefit from the acquisition. Cash-generating units to which goodwill has been allocated are tested for impairment at least annually, or more frequently when there is an indication that the unit may be impaired. If the recoverable amount of the cash-generating unit is less than the carrying amount of the unit, the impairment loss is allocated first to reduce the carrying amount of any goodwill allocated to the unit and then to other assets of the unit pro-rata on the basis of the carrying amount of each asset in the unit.

THE NURSERY RESEARCH & PLANNING LIMITED (REGISTERED NUMBER: 04251937)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2024

2. ACCOUNTING POLICIES - continued

Intangible assets
Intangible assets acquired separately from a business are recognised at cost and are subsequently measured at cost less accumulated amortisation and accumulated impairment losses.

Intangible assets acquired on business combinations are recognised separately from goodwill at the acquisition date where it is probable at the expected future economic benefits that are attributable to the asset will flow to the entity and the fair value of the asset can be measured reliably; the intangible asset arises from contractual or other legal rights; and the intangible asset is separable from the entity.

Amortisation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives only following bases:

Integration costs 2 years and 7 months straight line

Tangible fixed assets
Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Fixtures and fittings 3 years straight line
Computer equipment 3 years straight line

The gain or loss arising only disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to the profit and loss account.

Investments in subsidiaries
Investments in subsidiary undertakings are recognised at cost.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


THE NURSERY RESEARCH & PLANNING LIMITED (REGISTERED NUMBER: 04251937)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2024

2. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Foreign exchange
Assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rate of exchange ruling at the date of transaction. Exchange differences are taken into account in arriving at the operating result.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 43 (2023 - 44 ) .

4. INTANGIBLE FIXED ASSETS
Goodwill
£   
COST
At 1 January 2024
and 31 December 2024 242,534
AMORTISATION
At 1 January 2024 97,013
Charge for year 24,253
At 31 December 2024 121,266
NET BOOK VALUE
At 31 December 2024 121,268
At 31 December 2023 145,521

THE NURSERY RESEARCH & PLANNING LIMITED (REGISTERED NUMBER: 04251937)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2024

5. TANGIBLE FIXED ASSETS
Fixtures
and Computer
fittings equipment Totals
£    £    £   
COST
At 1 January 2024 16,031 61,382 77,413
Additions 1,659 14,906 16,565
Disposals (15,711 ) (19,252 ) (34,963 )
At 31 December 2024 1,979 57,036 59,015
DEPRECIATION
At 1 January 2024 15,256 47,487 62,743
Charge for year 842 10,541 11,383
Eliminated on disposal (15,517 ) (18,545 ) (34,062 )
Reclassification/transfer - 4,863 4,863
At 31 December 2024 581 44,346 44,927
NET BOOK VALUE
At 31 December 2024 1,398 12,690 14,088
At 31 December 2023 775 13,895 14,670

6. FIXED ASSET INVESTMENTS
Shares in
group
undertakings
£   
COST
At 1 January 2024
and 31 December 2024 2
NET BOOK VALUE
At 31 December 2024 2
At 31 December 2023 2

7. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.12.24 31.12.23
£    £   
Trade debtors 1,212,092 1,297,505
Amounts owed by group undertakings - 12,000
Other debtors 489,397 774,828
1,701,489 2,084,333

THE NURSERY RESEARCH & PLANNING LIMITED (REGISTERED NUMBER: 04251937)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2024

8. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.12.24 31.12.23
£    £   
Trade creditors 269,790 291,269
Amounts owed to group undertakings 124 256,058
Taxation and social security 504,280 707,429
Other creditors 683,717 900,967
1,457,911 2,155,723

9. LEASING AGREEMENTS
At the reporting end date the company had outstanding commitments for future minimum lease payments under non-cancellable operating leases, as follows:

2024 2023

£246,750 £447,541

10. RELATED PARTY DISCLOSURES

The company has taken advantage of exemption, under the terms of Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland', not to disclose related party transactions with wholly owned subsidiaries within the group.

11. ULTIMATE CONTROLLING PARTY

The company is controlled by an employee ownership trust known as "The Nursery Research & Planning Employee Ownership Trust". The purpose of the trust is to hold shares in the company for the benefit of employees of The Nursery Research & Planning Limited.

As at 31 December 2024, the entire shareholding of the company was held by the Trust.